GABA

Animal Physiology Behavioral Neuroscience Neuroscience

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
25 Oct 2019
Historique:
received: 08 04 2019
revised: 13 08 2019
accepted: 23 09 2019
pubmed: 15 10 2019
medline: 15 10 2019
entrez: 15 10 2019
Statut: ppublish

Résumé

Binge eating could contribute to the development of obesity, and previous studies suggest that gamma-aminobutyric acid (GABA) type B receptor (GABA

Identifiants

pubmed: 31610370
pii: S2589-0042(19)30370-0
doi: 10.1016/j.isci.2019.09.032
pmc: PMC6817655
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

337-347

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Neuroscience. 2016 Apr 5;319:233-45
pubmed: 26791525
Neurosci Biobehav Rev. 2016 Apr;63:223-38
pubmed: 26850211
Eur J Neurosci. 2014 Jun;39(11):1921-32
pubmed: 24460847
Pharmacol Biochem Behav. 2008 Jun;89(4):581-90
pubmed: 18353432
Behav Pharmacol. 2012 Sep;23(5-6):616-25
pubmed: 22854310
Nat Rev Neurosci. 2008 Jul;9(7):545-56
pubmed: 18545266
Nat Rev Neurosci. 2012 May 18;13(6):380-94
pubmed: 22595784
J Clin Psychopharmacol. 2015 Jun;35(3):357-9
pubmed: 25928704
Neuron. 2006 Sep 21;51(6):801-10
pubmed: 16982424
Appetite. 2013 May;64:62-70
pubmed: 23321345
J Clin Invest. 2014 Oct;124(10):4351-62
pubmed: 25157819
Physiol Behav. 2013 Apr 10;114-115:21-31
pubmed: 23499930
Obesity (Silver Spring). 2008 Sep;16(9):1998-2002
pubmed: 19186326
Physiol Behav. 2014 Apr 10;128:70-9
pubmed: 24518863
Cell Metab. 2011 Jun 8;13(6):720-8
pubmed: 21641553
FEBS Lett. 2007 Oct 16;581(25):4857-64
pubmed: 17888909
Am J Physiol Regul Integr Comp Physiol. 2006 Nov;291(5):R1236-9
pubmed: 16763080
J Neurosci. 2014 Apr 2;34(14):5012-22
pubmed: 24695718
Int J Eat Disord. 2007 Dec;40(8):687-91
pubmed: 17647277
Physiol Behav. 1998 Dec 1;65(3):545-53
pubmed: 9877422
Neurosci Biobehav Rev. 2006;30(2):215-38
pubmed: 16099045
Transgenic Res. 2013 Dec;22(6):1241-7
pubmed: 23624740
Nat Rev Neurosci. 2011 Oct 20;12(11):638-51
pubmed: 22011680
J Neurosci. 2016 Nov 9;36(45):11469-11481
pubmed: 27911750
Nat Neurosci. 2012 Nov;15(11):1547-55
pubmed: 23064379
Am J Physiol Regul Integr Comp Physiol. 2008 Aug;295(2):R463-71
pubmed: 18525013
Psychoneuroendocrinology. 2015 Oct;60:206-16
pubmed: 26186250
Exp Anim. 2013;62(4):295-304
pubmed: 24172193
Neuropharmacology. 2015 Jan;88:36-47
pubmed: 24971600
Behav Pharmacol. 2009 Oct;20(7):631-4
pubmed: 19752722
Pharmacol Biochem Behav. 2009 May;92(3):528-36
pubmed: 19217918
Eur J Neurosci. 2009 Aug;30(3):397-414
pubmed: 19656174
J Neurosci. 2013 Oct 23;33(43):17166-73
pubmed: 24155320
Annu Rev Neurosci. 2001;24:167-202
pubmed: 11283309
Physiol Rev. 2004 Jul;84(3):835-67
pubmed: 15269338
Health Aff (Millwood). 2009 Sep-Oct;28(5):w822-31
pubmed: 19635784
Cell Metab. 2015 Dec 1;22(6):962-70
pubmed: 26603190
Nat Neurosci. 2010 May;13(5):635-41
pubmed: 20348917
Nature. 2009 Nov 19;462(7271):307-14
pubmed: 19924209
Physiol Behav. 2005 Sep 15;86(1-2):176-84
pubmed: 16140347
CNS Spectr. 2015 Dec;20(6):574-83
pubmed: 26514168
Obesity (Silver Spring). 2010 Sep;18(9):1710-7
pubmed: 20300082

Auteurs

Taku Tsunekawa (T)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

Ryoichi Banno (R)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan; Research Center of Health, Physical Fitness and Sports, Nagoya University, Nagoya 464-8601, Japan. Electronic address: ryouichi@med.nagoya-u.ac.jp.

Hiroshi Yaginuma (H)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

Keigo Taki (K)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

Akira Mizoguchi (A)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

Mariko Sugiyama (M)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

Takeshi Onoue (T)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

Hiroshi Takagi (H)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

Daisuke Hagiwara (D)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan; Schaller Research Group on Neuropeptides, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Yoshihiro Ito (Y)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan; Department of CKD Initiatives/Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

Shintaro Iwama (S)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

Motomitsu Goto (M)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

Hidetaka Suga (H)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.

Bernhard Bettler (B)

Department of Biomedicine, University of Basel, Basel 4056, Switzerland.

Hiroshi Arima (H)

Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan. Electronic address: arima105@med.nagoya-u.ac.jp.

Classifications MeSH